Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Medical Aesthetics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029" report has been added to ResearchAndMarkets.com's offering.
The medical aesthetics market is set to reach US$ 30 billion by 2029 from above US$ 11.5 billion in 2019 promoting outstanding growth at a compounded annual growth rate (CAGR) of 9.9 % during the forecast period from 2021 to 2029.
Approximately over 47 million surgical procedures take place in America alone and the potential in emerging countries is expanding. During the pandemic elective healthcare institutes prioritized emergency surgeries depending on patient's current health status and potential of threat. Therefore, elective surgeries took a back seat and added to the waiting list of patient that was already waiting for surgeries. The elective surgeries, therefore have not yet resumed to the normal case scenario. However, with the introduction of vaccines in many countries, especially to healthcare workers has reduced the risk of Covid-19 infection. Therefore, healthcare institutes are expected to gradually normalize the elective surgery with effective precautions in place.
Most popular surgeries vary as per the gender. Women contribute approximately ten folds larger market than men for medical aesthetics market due to higher awareness levels among women.
Rhinoplasty, breast augmentation and gluteal implants are most popular among women. Liposuction, eyelid uplift and gynecomastia were preferred by men. While non surgical aesthetic solutions displayed no difference in trend by gender. Botulinum toxins, hyaluronic acids, chemical peels and laser skin resurfacing solutions topped the list of non surgical aesthetic solutions. Lack/limited reimbursement for many medial aesthetics surgeries is the largest challenges as the cost of these surgeries are also high. Frequent product recalls, perceived risk and social stigma have limited the growth of the market.
Highest Level of Aged Population than Ever before Boosting the Facial Aesthetics market
As per studies conducted by UN - the rate of population ageing in the 21 century will surpass the previous century. The number of people aged 60 years and above has tripled since 1950. It is estimated that senior and geriatric population will reach 2.1 billion by 2050. This trend is increasing the takers for facial aesthetics. Companies are increasing their investment in R&D to innovate new solutions to meet the demand. 3D technology is deployed for making facial prosthesis enabling higher level of precision in creating skeletal model of patients including bone defects if any. Molds are then created to perfectly fit the skeletal model by impressing biomaterial. Celebrity endorsed advertisements have led to increase in the use of facial care products such as anti-aging, anti-wrinkle, oxygenation, rejuvenation neurotoxin free botulinum and so on. Dental implants have been successful in treating dental deformities and congenital maxillofacial defects. Vascular lesions, dark tattoo removal and skin toning are performed through cosmetic lasers. Other minimally invasive procedure that was in demand is laser treatment for hair removal, scare, mole and acne treatment.
Rhinoplasty surgery, forehead lift, facelift, dermabrasion were surgeries in demand. Liposuction, abdominoplasty, gluteal implants undoubtedly have significant demand due to rising prevalence of obesity and increasing awareness. Other solutions such as photorejuenation, body contouring aesthetics are expected to evidence positive growth trends during the forecast period of 2021 to 2029. However, there are specific concerns when it comes to certain surgical solutions. For example: Many studies have found that breast augmentation do not cause or increase the chances of breast cancers, however, 1 in 50,000 women has acquired a rare kind of cancer called anaplastic large-cell lymphoma (ALCL). There are further studies to understand the long term impact of surgical implants in the human body. Such studies do have significant impact on market performance of solutions.
North America Witnesses the Highest Demand Driven by Increased Awareness Levels
North America contributes highest to the market revenues of medical aesthetics market. Increasing awareness level and access to novel technologies is enabling the market growth. Domestic market players are well equipped with latest technologies pertaining to minimally invasive procedures and laser therapies. Dental aesthetics are quite popular in Europe due to rising prevalence of dental deformities in Europe, additionally access to sophisticated technology is driving the market revenues in Europe. APAC region is expected to register highest growth rate during the forecast period. Increasing awareness, rise in per capita income; increasing influence of western countries and the beauty industry have led to strong demand in this region for medical aesthetics market. Other developing economies such as Middle East, Africa, Latin America are witnessing moderate to high growth, with a scope for new market players to establish themselves via chain of franchised chain of domestic and international players.
Historical & Forecast Period
This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segment are calculated for the forecast period from 2021 to 2029.
Key market players in the medical aesthetics market include Allergan, Plc., Dentsply Sirona, Establishment Labs, Galderma S.A., Implantech, Johnson & Johnson, Merz Pharma GmbH, SculpSure, and VENUSCONCEPT.
Key questions answered in this report
- What are the key market segments in current scenario and in the future by product categories
- What are the key market segments in current scenario and in the future by regions
- What is the key impact of Covid 19 over market revenues and market determinants in the medical aesthetics market?
- What are the primary and secondary macro and micro factors influencing the market growth currently and during the forecast period?
- What are the primary and secondary macro and micro factors deterring the market growth currently and during the forecast period?
- How to overcome the current market challenges and leverage the opportunities in each of the market segment?
- Who are the key players in the medical aesthetics market and what are their key product categories and strategies?
- What are the key strategies - mergers/acquisitions/R&D/strategic partnerships etc that companies are deploying to enhance market revenues and growth?
Key Topics Covered:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Reviewa
1.3.7. Assumptions
1.4. Market Segmentation
1.5. Impact of Covid 19
Chapter 2. Executive Summary
2.1. Global MA Market Portraiture
2.2. Global MA Market, by Product, 2019 (US$ Mn)
2.3. Global MA Market, by Geography, 2019 (US$ Mn)
Chapter 3. Medical Aesthetics (MA) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2019
3.6. Competitive Analysis: Global MA Market, by Key Players, 2019
Chapter 4. Global Medical Aesthetics (MA) Market, by Product
4.1. Overview
4.2. Dental Implant
4.3. Breast Implant
4.4. Facial Aesthetics
4.5. Laser-Based Aesthetics
4.6. Body Contouring Aesthetics
4.7. Others
Chapter 5. Global Medical Aesthetics (MA) Market, by Geography
5.1. Overview
5.2. North America MA Market Analysis, 2019 - 2029
5.2.1. North America MA Market, by Product, 2019 - 2029 (US$ Mn)
5.2.2. North America MA Market, by Country, 2019 - 2029 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe MA Market Analysis, 2019 - 2029
5.3.1. Europe MA Market, by Product, 2019 - 2029 (US$ Mn)
5.3.2. Europe MA Market, by Country/Region, 2019 - 2029 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific MA Market Analysis, 2019 - 2029
5.4.1. Asia Pacific MA Market, by Product, 2019 - 2029 (US$ Mn)
5.4.2. Asia Pacific MA Market, by Country/Region, 2019 - 2029 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America MA Market Analysis, 2019 - 2029
5.5.1. Latin America MA Market, by Product, 2019 - 2029 (US$ Mn)
5.5.2. Latin America MA Market, by Country/Region, 2019 - 2029 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East and Africa MA Market Analysis, 2019 - 2029
5.6.1. MEA MA Market, by Product, 2019 - 2029 (US$ Mn)
5.6.2. MEA MA Market, by Country/Region, 2019 - 2029 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Allergan, Plc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Alma Lasers, Ltd.
6.3. Dentsply Sirona
6.4. Establishment Labs
6.5. Galderma S.A.
6.6. Implantech
6.7. Johnson and Johnson
6.8. Merz Pharma GmbH
6.9. SculpSure
6.10. VENUSCONCEPT
For more information about this report visit https://www.researchandmarkets.com/r/353uqx